20May 2017

PREPARATION AND CHARACTERIZATION OF SHRIMP DERIVED CHITOSAN AND EVALUATION OF ITS EFFICIENCY AS BEE VENOM DELIVERY FOR CANCER TREATMENT.

  • Faculty of Science, Al-Azhar University (Girls branch).
  • The Holding Company for Production of Vaccines, Sera and Drugs (VACSERA).
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Chitosan is an amino polysaccharide prepared by processing shrimp skeleton wastes which involves partial deacetylation of chitin. Many biochemists have found that chitosan as biocompatible, biodegradable and non toxic compound which made wide applicability in conventional pharmaceutics as a potential formulation excipient. The nanoparticles were loaded with venom of Apismelliferabees and cytotoxicity against colon cancer (CaCO2) was evaluated. The crude chitin was collected from exoskeleton of Penaeuskerathurus specimens and was processed to obtain chitosan(CS). Chitosan nanoparticles (CS NPs) were prepared by the ionotropic gelation method of chitosan cations with sodium tripolyphosphate (TPP) anions.The encapsulation efficiency and loading capacity of the bee venom on the prepared chitosan nanoparticles were evaluated. The cytotoxicity of bee venom (BV) alone,chitosan nanoparticles andbee venom loaded chitosan nanoparticles againstCaCo2 cells was conducted using MTT staining assay.Data recorded revealed thatthe combination of bee venom (BV) with chitosan nanoparticles enhanced the inhibitory effect on colon cancer cells more than treatment with BV alone and chitosan nanoparticles without venom.


  1. Badawy, M.E.I. and Rabea, E.I. (2011): A biopolymer chitosan and its derivatives as promising antimicrobial agents against plant pathogens and their applications in crop protection.International Journal of Carbohydrate Chemistry, 2011: 1-29.
  2. Bagheri-Khoulenjani,S. ;Taghizadeh, S. M. and Mirzadeh, H. (2009): An investigation on the short-term biodegradability of chitosan with various molecular weights and degrees of deacetylation. Carbohydrate Polymers, 78 (4): 773-778.
  3. Baxter, A.; Dillon, M.; Anthony Taylor, K. D. and Roberts, G. A. F. (1992): Improved method for i.r. determination of the degree of N-acetylation of chitosan. International Journal of Biological Macromolecules, 14 (3): 166-169.
  4. Bhowmik,T. ; Saha,P. P.; Dasgupta, A. and Gomes, A. (2013):Antileukemic potential of PEGylated gold nanoparticle conjugated with protein toxin (NKCT1) isolated from Indian cobra (Najakaouthia) venom. Cancer Nano, 4:39?
  5. Bradford, M. (1976): A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72: 248-54.
  6. Brine, C.J. and Austin, P.R. (1981): Chitin variability with species and method of preparation. Comp. Biochem. Physiol. 69B: 283-286.
  7. Delorino, M.A. and Cresidio, S.P. (2009): Investigation of chitosan from squid pen as Scar Remover. World Appl. Sci. J., 5: 98-103.
  8. Dinarvand, R.; Sepehri, N.; Manoochehri, S.; Rouhani, H. and Atyabi, F. (2011):Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. J. Nanomedicine,6 : 877-895.
  9. Divya, K.;Rebello, S. and Jisha M. S. (2014): A Simple and Effective Method for Extraction of High Purity Chitosan from Shrimp Shell Waste. Proc. of the Intl. Conf. on Advances In Applied Science and Environmental Engineering, 141-145.
  10. Dounighi, M.N.;Behfar, A.;Ezabadi, A.;Zolfagharian, H. andHeydari, M. (2010): Preparation of chitosan nanoparticles containing Najanajaoxiana snake venom. Nanomedicine: Nanotechnology, Biology andMedicine 6(1):137-43.
  11. Dounighi, N.; Eskandari, R.; Avadi, M.R.; Zolfagharian, H.; Mir Mohammad Sadeghi, A. and Rezayat, M. (2012a): Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthuseupeusscorpion venom as an antigen delivery system.The Journal of Venomous Animals and Toxins including Tropical Diseases, 18 (1): 44-52.
  12. Dounighi, N.; Damavandi, M. ;Zolfagharian, H. and Moradi, S.(2012b): Preparing and Characterizing Chitosan Nanoparticles Containing HemiscorpiuslepturusScorpion Venom as an Antigen Delivery System. Archives of Razi Institute, 67 (2): 145-153.
  13. Dounighi, N.;Mehrabi, M.;Avadi, M.R.;Zolfagharian, H. and Rezayat, M. (2015): Preparation, characterization and stability investigation of chitosan nanoparticles loaded with the Echiscarinatussnake venom as a novel delivery system. Archives of Razi Institute, 70 (4):269-277.
  14. Faraji, AH andWipf, P. (2009): Nanoparticles in cellular drug delivery. Bioorg Med Chem 17:2950?2962
  15. Gan, Q.; Wang, T.; Cochrane, C. and McCarron, P. (2005): Modulation of surface charge, particle size and morphological properties of chitosan?TPP nanoparticles intended for gene delivery. Colloids Surfaces B., 44(2-3):65-73.
  16. Gan, Q. and Wang, T. (2007): Chitosan nanoparticles as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surfaces B., 59(1):24-34.
  17. Gerlier, D. and Thomasset, N. (1986). Use of MTT colorimetric assay to measure cell activation. Immunol. methods, 94(1-2):57- 63.
  18. Ghosh, P.; Han, G.; De, M.; Kim, C.K. andRotello, V.M. (2008): Gold nanoparticles in delivery applications. Adv Drug Deliver Rev 60:1307?1315
  19. Goodarzi, N.; Ghahremani, M. H. ; Amini, M.; Atyabi, F.; Ostad, S. N. ; ShabaniRavari, N.; Nateghian, N. and Dinarvand, R.(2014): CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system. Biol. Drug Des.,83(6):741-752.
  20. Hajji, S.; Younes, I.; Rinaudo, M.; Jellouli, K.andNasri, M. (2015): Characterization and In Vitro Evaluation of Cytotoxicity, Antimicrobial and Antioxidant Activities of Chitosans Extracted from Three Different Marine Sources. ApplBiochemBiotechnol, 177(1): 18-35.
  21. Hejazi, R. and Amiji, M. (2003): Chitosan-based gastrointestinal delivery systems. Journal of Controlled Release 89: 1?165.
  22. Hossain, M. S. and Iqbal, A. (2014): Production and characterization of chitosan from shrimp waste. J. Bangladesh Agril. Univ. 12(1): 153?160.
  23. Hu, C.M.J. and Zhang, L. (2012): Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. BiochemPharmacol 83:1104?1111
  24. Hui, R.C.; Francis, R.E.; Guest, S.K.; Costa, J.R.; Gomes, A.S.; Myatt, S.S.et al(2008): Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Mol Cancer Ther 7:670?
  25. Ip, S.W.; Chu, Y.L.; Yu, C.S.; Chen, P.Y.; Ho, H.C.; Yang, J.S.; Huang, H.Y.;Chueh, F.S.; Lai, T.Y. and Chung, J.G. (2012): Bee venom induces apoptosis through intracellular Ca2+ -modulated intrinsic death pathway in human bladder cancer cells. International journal of urology: official journal of the Japanese Urological Association. 19:61?70.
  26. Ip, S.W.; Liao, S.S.; Lin, S.Y.; Lin, J.P.; Yang, J.S.; Lin, M.L.; Chen, G.W.;Lu, H.F.;Janakiram, N.B. andRao, C.V. (2014): The role of inflammation in colon cancer. AdvExp Med Biol. 816:25?52.
  27. Jo, M.; Park, M.H.;Kollipara, P.S., An, B.J.; Song, H.S., Han, S.B.; Kim, J.H.; Song, M.J. and Hong, J.T. (2012): Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and applied pharmacology. 258:72?81.
  28. Kamala, K. ;Sivaperumal, P. and Rajaram, R.(2013): Extraction and Characterization of Water Soluble Chitosan from ParapeneopsisStylifera Shrimp Shell Waste and Its Antibacterial Activity. International Journal of Scientific and Research Publications, 3 (4): 1-8.
  29. Kucukgulmez, A.; Celik, M.; Yanar, Y; Sen, D. ;Polat, H. and Kadak, A.E. (2011): Physicochemical characterization of chitosan extracted from Metapenaeusstebbingi shells. Food Chemistry 126: 1144?1148
  30. Lam, T.D.; Hoang, V.D.; Lien, L.N.;Thinh, N.N. andDien, P.G. (2006): Synthesis and characterization of chitosan nanoparticles used as drug. J Chem, 44:105?109.
  31. Li, Q.; Dunn, E.T.;Grandmaison, E.W. andGoosen, M. F. A. (1997): Applications and properties of chitosan. In: Applications of chitin and chitosan. Goosen M. F. A. (ed), pp. 3-29,Technomic Publishing Company, Lancaster.
  32. Li, Q.; Dunn, E.T.; Grandmaison, E.W. and Goosen, M.F.A. (1992): Applications and properties of chitosan. Journal of Bioactive Compatible Polymers, 7, 370?397.
  33. Lin, M.W.; Han, S.M. and Chung, J.G. (2008): The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. In Vivo, 22(2):237?245.
  34. Long, J.H.W.S. (2013):Synthesis and characterization of chitosan from shrimp shells. A project report submitted in partial fulfilment of the requirements for the award of Bachelor of Engineering (Hons.) Faculty of Engineering and Science UniversitiTunku Abdul Rahman.
  35. Luo, H.; Li, J.and Chen, X. (2009): Antitumor effect of N-succinyl-chitosannanoparticles on K562 cells. Biomedecine& pharmacotherapy, 64(8):521-526.
  36. Mohanraj, V.J and Chen, Y (2006):Nanoparticles ? A Review.Tropical Journal of Pharmaceutical Research, 5 (1): 561-573.
  37. Monarul, I.Md.;Masum, S.Md.; Mahbubur, R.M.; Md. Ashraful Islam, M.Md.; Shaikh, A.A. and Roy, S.K. (2011): Preparation of Chitosan from Shrimp Shell and Investigationof Its Prop-erties. International Journal of Basic & Applied Sciences, 11(1): 116-130.
  38. Moon, D.O.; Park, S.Y.;Heo, M.S.; Kim, K.C.; Park, C.;Ko, W.S.; Choi, Y.H. and Kim, G.Y.(2006): Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. International immunopharmacology. 6:1796?1807.
  39. Muzzarelli, R. A. A. (1985): Chitin. In: "The polysaccharides" (G.O. Aspinall, ed), 3: 417? 450. Academic Press, New York.
  40. No, H.K. and Lee, M.Y. (1995): Isolation of Chitin from Crab Shell Waste. Journal Korean Soc. Food Nutrition, 24(1):105-113.
  41. Park, H.J.; Son, D.J.; Lee, C.W.; Choi, M.S.; Lee, U.S.; Song, H.S.; Lee, J.M. and Hong, J.T. (2007):Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IkappaB kinase. Biochemical pharmacology. 73:237?247.
  42. Park, M.H.; Choi, M.S.;Kwak, D.H.; Oh, K.W.; Yoon, D.Y.; Han, S.B.; Song, H.S.; Song, M.J. and Hong, J.T. (2011): Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB. The Prostate. 71:801?812.
  43. Patria, A. (2013): Production and characterization of Chitosan from shrimp shells waste. AACL Bioflux, 6 (4): 339-344.
  44. Putz, T.; Ramoner, R.; Gander, H.,; Rahm, A.;Bartsch, G.; Bernardo, K.; Ramsay, S.and Thurnher, M. (2007): Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate sig?nal transduction and inhibit proliferation of renal cancer cells. Cancer immunology, immunotherapy: CII. 56:627?640.
  45. Puvvada,Y.S. ;Vankayalapati, S. andSukhavasi, S.(2012): Extraction of chitin from chitosan from exoskeleton of shrimp for application in the pharmaceutical industry. International Current Pharmaceutical Journal, 1(9): 258-263.
  46. Rocha Soares, K.S.; Cardozo Fonseca, J.L.; Oliveira Bitencourt, M.A.; Santos, K.S.C.R.; Silva-J?nior, A.A. and Fernandes-Pedrosa, M.F. (2012): Serum production against Tityusserrulatus scorpion venom using cross-linked chitosan nanoparticles as immunoadjuvant. Toxicon 60: 1349?1354.
  47. Sahoo, S.K. andLabhasetwar, V. (2005): Enhanced anti-proliferative activity of transferring conjugated paclitaxel loaded nanoparticle is mediated via sustained intracellular drug retention. Mol Pharm 2:373?
  48. Sayari,E.; Dinarvand, M.; Amini, M.; Azhdarzadeh, M. ; Mollarazi, E.; Ghasemi, Z. and Atyabi, F. (2014):MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. J. Pharm., 473(1), 304-315.
  49. Sewvandi, G.A. and Adikary, S.U. (2012): Synthesizing and Characterization of Natural Biopolymer Chitosan Derived from Shrimp Type, Tropical Agricultural Research, 23 (3): 272 -276.
  50. Son, D.J.; Lee, J.W.; Lee, Y.H.; Song, H.S.; Lee, C.K. and Hong, J.T. (2007): Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent com?pounds. Pharmacology & therapeutics. 115:246?270.
  51. Suhardi (1993):KhitindanKitosan. BukuMonograf, PusatAntarUniversitasPangandanGizi UGM, Yogyakarta, 272-278.
  52. Swiderska, M.;Choromanska, B.;Dabrowska, E.;Konarzewska- Duchnowska, E.;Choromanska, K.;Szczurko, G.;Mysliwiec, P.;Dadan, J.;Ladny, J.R. andZwierz, K. (2014): The diagnostics of colorectal cancer. ContempOncol (Pozn). 18:1?6.
  53. Tammam, S.N.;Azzazy, H.M.E.;Breitinger, H.G. and Lamprecht, A. (2015): Chitosan Nanoparticles for Nuclear Targeting; the Effect of Nanoparticle Size and Nuclear Localization Sequence Density. Molecular Pharmaceutics, 1155: 1-23.
  54. Tiwari, P.M.;Vig, K.; Dennis, V.A. and Singh, S.R. (2011): Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1:31?63
  55. Venkatesan, C.;Vimal, S. and SahulHameed, A. S. (2013): Synthesis and Characterization of Chitosan Tripolyphosphate Nanoparticles and its Encapsulation Efficiency Containing Russell?s Viper Snake Venom. J BiochemMoelcular Toxicology, Volume 00, Number 0:1-6.
  56. Wang, C.; Chen, T.; Zhang, N.; Yang, ; Li, B.; Lu, X.; Cao, X. and Ling, C. (2009):Melittin, a major component of bee venom, sen?sitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkappaB. The Journal of biological chemistry,? 284: 3804?3813.
  57. Wang, W.; Bo, S.Q.; Li, S.Q. and Qin, W. (1991): Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. International Journal of Biological Macromolecules,13: 281-285.
  58. Wu, Y.; Yang, W.; Wang, C.; Hu, J. and Fu, S. (2005): Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm., 295(1-2):235-45.
  59. Yacob, N.; Talip, N.; Mahmud, M.; Sani, N.A.I.M.; Samsuddin, N.A. and Fabillah, N.A. (2013): Determination of viscosity-avarage molecular weight of chitosan using intrinsic viscosity measurement. JOURNAL of NUCLEAR and Related TECHNOLOGIES, 10 (1): 39-44.
  60. Yang, X.;Koh, C.G.; Liu, S.; Pan, X.;Santhanam, R.; Yu, B. et al (2009): Transferring receptor targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm, 6:221?
  61. Yen, M.T.; Yang, J.H. and Mau, J.L.? (2009): Physicochemical characterization of chitin andchitosan from crab shells. Carbohydratepolymers, 75(1): 15-21.
  62. Zhang, H.L.; Wu, S.H.; Tao, Y.; Zang, L.Q. and Su, Z.Q. (2010): Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J Nanomaterials, 2010: 1-5.
  63. Zheng,; Lee, H. L.; Ham, Y.W.; Song, H.S.; Song, J. and Hong, J.T. (2015):?? Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget, 6, (42): 44437-44451.
  64. Zhou, S.; Deng, X.; Yuan, M. and Li, X.(2002): Investigation on preparation and protein release of biodegradable polymer microspheres as Drug-Delivery system. Journal of Applied Polymer Science 84: 778-784.
  65. Zhou, S.; Liao, X.; Liang, Z.; Li, X.; Deng, X. and Li, H.(2004): Preparation and characterization of biodegradable microspheres containing Hepatitis B surface antigen. Macromolecular Bioscience, 4: 47- 52.
  66. Zhou, X.M. and Li, X.H. (2001): Investigation on a novel core-coated microspheres protein delivery system. Journal of Controlled Release 75: 27-36.

[Fatma. A. Taher, Walaa. A. Moselhy, Aly. F. Mohamed, Samia. E. El-Didamony, Karima. M. Metwalley and Zayed. A.B. (2017); PREPARATION AND CHARACTERIZATION OF SHRIMP DERIVED CHITOSAN AND EVALUATION OF ITS EFFICIENCY AS BEE VENOM DELIVERY FOR CANCER TREATMENT. Int. J. of Adv. Res. 5 (May). 370-388] (ISSN 2320-5407). www.journalijar.com


Aly, F. Mohamed
The Holding Company for Production of Vaccines, Sera and Drugs

DOI:


Article DOI: 10.21474/IJAR01/4122      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4122